Cargando…
260. Corticosteroid treatment in influenza virus and SARS-CoV-2 co-infected patients
BACKGROUND: Co-infections with SARS-CoV-2 and influenza virus may become more prevalent now that many countries are easing restrictions to reduce the spread of SARS-CoV-2. Co-infected patients are more likely to receive invasive mechanical ventilation (IMV) and have higher odds of in-hospital mortal...
Autores principales: | Swets, Maaike C, Russell, Clark, Harrison, Ewen, Docherty, Annemarie, Lone, Nazir, Girvan, Michelle, Hardwick, Hayley, Visser, Leonardus, Openshaw, Peter, Groeneveld, Geert, Semple, Calum, Baillie, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752261/ http://dx.doi.org/10.1093/ofid/ofac492.338 |
Ejemplares similares
-
SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses
por: Swets, Maaike C, et al.
Publicado: (2022) -
Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave
por: Read, Jonathan M, et al.
Publicado: (2021) -
Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study
por: Drake, Thomas M, et al.
Publicado: (2021) -
Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity
por: Swets, Maaike C., et al.
Publicado: (2023) -
Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study
por: Närhi, Fiina, et al.
Publicado: (2022)